Project D4198C00001 – A Phase II Open-Label, Multi-Center Study of MEDI4736 Evaluated as Single Agent or in Combination…

Basic data

Acronym:
D4198C00001
Title:
A Phase II Open-Label, Multi-Center Study of MEDI4736 Evaluated as Single Agent or in Combination with Tremelimumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Duration:
13/01/2016 to 12/01/2019
Abstract / short description:
A Phase II Open-Label, Multi-Center Study of MEDI4736 Evaluated as Single Agent or in Combination with Tremelimumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Keywords:
clinical trial
klinische Studie

Staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Södertälje, Sweden
Help

will be deleted permanently. This cannot be undone.